New Drugs FDA Approves Recorlev (levoketoconazole) for the Treatment of Endogenous Hypercortisolemia in Adult Patients With Cushing’s Syndrome 4 years ago
Pharma Industry News 2021 headlines: Pharma’s top five stumbles, spectacles and controversies 4 years ago
New Drug Applications Omeros Receives Complete Response Letter from FDA for Biologics License Application for Narsoplimab in the Treatment of HSCT-TMA 4 years ago
New Drug Applications Spero Therapeutics Submits New Drug Application to U.S. FDA for Tebipenem HBr for the Treatment of Complicated Urinary Tract Infections including Pyelonephritis 4 years ago
New Drug Applications Hyloris Announces FDA Acceptance of New Drug Application for Maxigesic IV in Post-Operative Pain 4 years ago
New Drug Applications Incyte Announces Acceptance of NDA for Parsaclisib for Three Types of Relapsed or Refractory Non-Hodgkin Lymphomas 4 years ago
New Drug Applications Amylyx Pharmaceuticals Submits New Drug Application (NDA) for AMX0035 for the Treatment of ALS 4 years ago
New Drug Applications FDA Grants Tentative Approval for Liquidia’s Yutrepia (treprostinil) Inhalation Powder 4 years ago
New Drug Applications Heron Therapeutics Announces Submission of HTX-019 NDA for the Prevention of Postoperative Nausea and Vomiting to FDA 4 years ago